GO:0008380 | RNA splicing | 2.88e-06 | 2.82e-02 | 3.828 | 6 | 21 | 165 |
GO:0000398 | mRNA splicing, via spliceosome | 1.54e-05 | 1.50e-01 | 3.931 | 5 | 15 | 128 |
GO:0003723 | RNA binding | 2.91e-05 | 2.85e-01 | 3.246 | 6 | 22 | 247 |
GO:0005654 | nucleoplasm | 3.00e-05 | 2.93e-01 | 2.157 | 10 | 68 | 876 |
GO:0010467 | gene expression | 3.63e-05 | 3.55e-01 | 2.546 | 8 | 49 | 535 |
GO:0006406 | mRNA export from nucleus | 1.83e-04 | 1.00e+00 | 4.735 | 3 | 7 | 44 |
GO:0006379 | mRNA cleavage | 2.24e-04 | 1.00e+00 | 6.440 | 2 | 2 | 9 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 3.41e-04 | 1.00e+00 | 6.150 | 2 | 4 | 11 |
GO:0035116 | embryonic hindlimb morphogenesis | 9.39e-04 | 1.00e+00 | 5.440 | 2 | 2 | 18 |
GO:0030529 | ribonucleoprotein complex | 1.15e-03 | 1.00e+00 | 3.837 | 3 | 5 | 82 |
GO:0042802 | identical protein binding | 1.78e-03 | 1.00e+00 | 2.464 | 5 | 15 | 354 |
GO:0005515 | protein binding | 2.50e-03 | 1.00e+00 | 0.770 | 18 | 198 | 4124 |
GO:0004832 | valine-tRNA ligase activity | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 1 |
GO:0031124 | mRNA 3'-end processing | 3.56e-03 | 1.00e+00 | 4.480 | 2 | 4 | 35 |
GO:0030900 | forebrain development | 3.76e-03 | 1.00e+00 | 4.440 | 2 | 2 | 36 |
GO:0006369 | termination of RNA polymerase II transcription | 4.18e-03 | 1.00e+00 | 4.362 | 2 | 5 | 38 |
GO:0006396 | RNA processing | 4.62e-03 | 1.00e+00 | 4.288 | 2 | 4 | 40 |
GO:0005846 | nuclear cap binding complex | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 2 |
GO:0035887 | aortic smooth muscle cell differentiation | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 2 | 2 |
GO:0019865 | immunoglobulin binding | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 2 |
GO:0010994 | free ubiquitin chain polymerization | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 2 |
GO:0048742 | regulation of skeletal muscle fiber development | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 2 |
GO:0001832 | blastocyst growth | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 2 |
GO:0007403 | glial cell fate determination | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 2 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 2 |
GO:0005634 | nucleus | 5.38e-03 | 1.00e+00 | 0.852 | 15 | 158 | 3246 |
GO:0006310 | DNA recombination | 7.15e-03 | 1.00e+00 | 3.966 | 2 | 8 | 50 |
GO:0002020 | protease binding | 7.15e-03 | 1.00e+00 | 3.966 | 2 | 3 | 50 |
GO:0071001 | U4/U6 snRNP | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 3 |
GO:0046914 | transition metal ion binding | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 3 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 2 | 3 |
GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 3 |
GO:0001835 | blastocyst hatching | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 3 |
GO:0005726 | perichromatin fibrils | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 3 |
GO:0048133 | male germ-line stem cell asymmetric division | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 3 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 7.72e-03 | 1.00e+00 | 3.909 | 2 | 8 | 52 |
GO:0045892 | negative regulation of transcription, DNA-templated | 8.04e-03 | 1.00e+00 | 2.301 | 4 | 17 | 317 |
GO:0042826 | histone deacetylase binding | 9.53e-03 | 1.00e+00 | 3.752 | 2 | 5 | 58 |
GO:0003407 | neural retina development | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 2 | 4 |
GO:0033093 | Weibel-Palade body | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 4 |
GO:0048562 | embryonic organ morphogenesis | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 4 |
GO:0045292 | mRNA cis splicing, via spliceosome | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 4 |
GO:0060318 | definitive erythrocyte differentiation | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 2 | 4 |
GO:0007599 | hemostasis | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 4 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 4 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.03e-02 | 1.00e+00 | 2.196 | 4 | 23 | 341 |
GO:0006464 | cellular protein modification process | 1.05e-02 | 1.00e+00 | 3.679 | 2 | 4 | 61 |
GO:0047485 | protein N-terminus binding | 1.19e-02 | 1.00e+00 | 3.587 | 2 | 6 | 65 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 1.26e-02 | 1.00e+00 | 3.543 | 2 | 5 | 67 |
GO:0035519 | protein K29-linked ubiquitination | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 2 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 2 | 5 |
GO:0005672 | transcription factor TFIIA complex | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 1 | 5 |
GO:0051488 | activation of anaphase-promoting complex activity | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 1 | 5 |
GO:0004521 | endoribonuclease activity | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 1 | 5 |
GO:0010458 | exit from mitosis | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 2 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 1 | 5 |
GO:0070307 | lens fiber cell development | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 1 | 5 |
GO:0030957 | Tat protein binding | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 1 | 5 |
GO:0006282 | regulation of DNA repair | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 2 | 5 |
GO:0044314 | protein K27-linked ubiquitination | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 2 | 5 |
GO:0048730 | epidermis morphogenesis | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 1 | 5 |
GO:0042382 | paraspeckles | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 3 | 5 |
GO:0051138 | positive regulation of NK T cell differentiation | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 1 | 5 |
GO:0030308 | negative regulation of cell growth | 1.37e-02 | 1.00e+00 | 3.480 | 2 | 3 | 70 |
GO:0001889 | liver development | 1.40e-02 | 1.00e+00 | 3.460 | 2 | 4 | 71 |
GO:0006281 | DNA repair | 1.45e-02 | 1.00e+00 | 2.529 | 3 | 24 | 203 |
GO:0001649 | osteoblast differentiation | 1.52e-02 | 1.00e+00 | 3.400 | 2 | 5 | 74 |
GO:0050847 | progesterone receptor signaling pathway | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 6 |
GO:0006346 | methylation-dependent chromatin silencing | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 6 |
GO:0085020 | protein K6-linked ubiquitination | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 6 |
GO:0002199 | zona pellucida receptor complex | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 4 | 7 |
GO:0008409 | 5'-3' exonuclease activity | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 2 | 7 |
GO:0007617 | mating behavior | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 1 | 7 |
GO:0000339 | RNA cap binding | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 1 | 7 |
GO:0001823 | mesonephros development | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 1 | 7 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 2 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 2 | 7 |
GO:0035136 | forelimb morphogenesis | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 4 | 7 |
GO:0061036 | positive regulation of cartilage development | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 2 | 7 |
GO:0030198 | extracellular matrix organization | 1.82e-02 | 1.00e+00 | 2.407 | 3 | 7 | 221 |
GO:0005845 | mRNA cap binding complex | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 8 |
GO:0006878 | cellular copper ion homeostasis | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 8 |
GO:0031011 | Ino80 complex | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 3 | 8 |
GO:0010388 | cullin deneddylation | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 4 | 8 |
GO:0070182 | DNA polymerase binding | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 8 |
GO:0045778 | positive regulation of ossification | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 8 |
GO:0031091 | platelet alpha granule | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 8 |
GO:0071354 | cellular response to interleukin-6 | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 1 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 3 | 9 |
GO:0010225 | response to UV-C | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 2 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 2 | 9 |
GO:0005739 | mitochondrion | 2.37e-02 | 1.00e+00 | 1.567 | 5 | 32 | 659 |
GO:0001967 | suckling behavior | 2.53e-02 | 1.00e+00 | 5.288 | 1 | 4 | 10 |
GO:0043923 | positive regulation by host of viral transcription | 2.53e-02 | 1.00e+00 | 5.288 | 1 | 1 | 10 |
GO:0005095 | GTPase inhibitor activity | 2.53e-02 | 1.00e+00 | 5.288 | 1 | 1 | 10 |
GO:0071564 | npBAF complex | 2.53e-02 | 1.00e+00 | 5.288 | 1 | 3 | 10 |
GO:0032332 | positive regulation of chondrocyte differentiation | 2.78e-02 | 1.00e+00 | 5.150 | 1 | 1 | 11 |
GO:0008334 | histone mRNA metabolic process | 2.78e-02 | 1.00e+00 | 5.150 | 1 | 1 | 11 |
GO:0071565 | nBAF complex | 2.78e-02 | 1.00e+00 | 5.150 | 1 | 3 | 11 |
GO:0005730 | nucleolus | 2.91e-02 | 1.00e+00 | 1.168 | 7 | 74 | 1217 |
GO:0017025 | TBP-class protein binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 12 |
GO:0070577 | lysine-acetylated histone binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 12 |
GO:0006337 | nucleosome disassembly | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 2 | 13 |
GO:0007597 | blood coagulation, intrinsic pathway | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 2 | 13 |
GO:0016514 | SWI/SNF complex | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 3 | 13 |
GO:0005680 | anaphase-promoting complex | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 2 | 13 |
GO:0031589 | cell-substrate adhesion | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 1 | 13 |
GO:0060347 | heart trabecula formation | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 1 | 13 |
GO:0030902 | hindbrain development | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 2 | 14 |
GO:0043393 | regulation of protein binding | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 2 | 14 |
GO:0016575 | histone deacetylation | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 2 | 14 |
GO:0009880 | embryonic pattern specification | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 1 | 14 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 2 | 15 |
GO:0008135 | translation factor activity, nucleic acid binding | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 1 | 15 |
GO:0045638 | negative regulation of myeloid cell differentiation | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 4 | 15 |
GO:0030099 | myeloid cell differentiation | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 1 | 15 |
GO:0070932 | histone H3 deacetylation | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 2 | 15 |
GO:0016607 | nuclear speck | 3.85e-02 | 1.00e+00 | 2.679 | 2 | 8 | 122 |
GO:0005719 | nuclear euchromatin | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 2 | 16 |
GO:0003887 | DNA-directed DNA polymerase activity | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 2 | 16 |
GO:0000792 | heterochromatin | 4.27e-02 | 1.00e+00 | 4.522 | 1 | 1 | 17 |
GO:0005640 | nuclear outer membrane | 4.27e-02 | 1.00e+00 | 4.522 | 1 | 1 | 17 |
GO:0031047 | gene silencing by RNA | 4.51e-02 | 1.00e+00 | 4.440 | 1 | 2 | 18 |
GO:0006378 | mRNA polyadenylation | 4.51e-02 | 1.00e+00 | 4.440 | 1 | 3 | 18 |
GO:0000375 | RNA splicing, via transesterification reactions | 4.51e-02 | 1.00e+00 | 4.440 | 1 | 1 | 18 |
GO:0001105 | RNA polymerase II transcription coactivator activity | 4.76e-02 | 1.00e+00 | 4.362 | 1 | 2 | 19 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4.76e-02 | 1.00e+00 | 4.362 | 1 | 1 | 19 |
GO:0044822 | poly(A) RNA binding | 4.88e-02 | 1.00e+00 | 1.289 | 5 | 45 | 799 |
GO:0006913 | nucleocytoplasmic transport | 5.00e-02 | 1.00e+00 | 4.288 | 1 | 2 | 20 |
GO:0070979 | protein K11-linked ubiquitination | 5.00e-02 | 1.00e+00 | 4.288 | 1 | 3 | 20 |
GO:0034660 | ncRNA metabolic process | 5.00e-02 | 1.00e+00 | 4.288 | 1 | 1 | 20 |
GO:0043044 | ATP-dependent chromatin remodeling | 5.00e-02 | 1.00e+00 | 4.288 | 1 | 3 | 20 |
GO:0071897 | DNA biosynthetic process | 5.00e-02 | 1.00e+00 | 4.288 | 1 | 2 | 20 |
GO:0044212 | transcription regulatory region DNA binding | 5.13e-02 | 1.00e+00 | 2.450 | 2 | 13 | 143 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 2 | 21 |
GO:0043388 | positive regulation of DNA binding | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 2 | 21 |
GO:0051084 | 'de novo' posttranslational protein folding | 5.49e-02 | 1.00e+00 | 4.150 | 1 | 4 | 22 |
GO:0034504 | protein localization to nucleus | 5.49e-02 | 1.00e+00 | 4.150 | 1 | 1 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 5.49e-02 | 1.00e+00 | 4.150 | 1 | 1 | 22 |
GO:0045600 | positive regulation of fat cell differentiation | 5.49e-02 | 1.00e+00 | 4.150 | 1 | 1 | 22 |
GO:0030177 | positive regulation of Wnt signaling pathway | 5.73e-02 | 1.00e+00 | 4.086 | 1 | 1 | 23 |
GO:0016604 | nuclear body | 5.73e-02 | 1.00e+00 | 4.086 | 1 | 2 | 23 |
GO:0001103 | RNA polymerase II repressing transcription factor binding | 5.73e-02 | 1.00e+00 | 4.086 | 1 | 2 | 23 |
GO:0006370 | 7-methylguanosine mRNA capping | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 6 | 24 |
GO:0070534 | protein K63-linked ubiquitination | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 3 | 24 |
GO:0010827 | regulation of glucose transport | 6.21e-02 | 1.00e+00 | 3.966 | 1 | 7 | 25 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 6.21e-02 | 1.00e+00 | 3.966 | 1 | 3 | 25 |
GO:0030901 | midbrain development | 6.21e-02 | 1.00e+00 | 3.966 | 1 | 1 | 25 |
GO:0031492 | nucleosomal DNA binding | 6.21e-02 | 1.00e+00 | 3.966 | 1 | 3 | 25 |
GO:0009267 | cellular response to starvation | 6.46e-02 | 1.00e+00 | 3.909 | 1 | 1 | 26 |
GO:0001890 | placenta development | 6.46e-02 | 1.00e+00 | 3.909 | 1 | 2 | 26 |
GO:0016881 | acid-amino acid ligase activity | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 3 | 28 |
GO:0043966 | histone H3 acetylation | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 4 | 28 |
GO:0050885 | neuromuscular process controlling balance | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 1 | 28 |
GO:0045893 | positive regulation of transcription, DNA-templated | 7.01e-02 | 1.00e+00 | 1.636 | 3 | 21 | 377 |
GO:0006418 | tRNA aminoacylation for protein translation | 7.17e-02 | 1.00e+00 | 3.752 | 1 | 4 | 29 |
GO:0008094 | DNA-dependent ATPase activity | 7.17e-02 | 1.00e+00 | 3.752 | 1 | 6 | 29 |
GO:0042733 | embryonic digit morphogenesis | 7.17e-02 | 1.00e+00 | 3.752 | 1 | 2 | 29 |
GO:0042752 | regulation of circadian rhythm | 7.17e-02 | 1.00e+00 | 3.752 | 1 | 5 | 29 |
GO:0006446 | regulation of translational initiation | 7.17e-02 | 1.00e+00 | 3.752 | 1 | 2 | 29 |
GO:0005524 | ATP binding | 7.20e-02 | 1.00e+00 | 1.131 | 5 | 37 | 892 |
GO:0000166 | nucleotide binding | 7.39e-02 | 1.00e+00 | 2.150 | 2 | 13 | 176 |
GO:0050681 | androgen receptor binding | 7.41e-02 | 1.00e+00 | 3.703 | 1 | 2 | 30 |
GO:0004842 | ubiquitin-protein transferase activity | 7.61e-02 | 1.00e+00 | 2.126 | 2 | 17 | 179 |
GO:0007077 | mitotic nuclear envelope disassembly | 7.89e-02 | 1.00e+00 | 3.610 | 1 | 9 | 32 |
GO:0015030 | Cajal body | 7.89e-02 | 1.00e+00 | 3.610 | 1 | 3 | 32 |
GO:0003713 | transcription coactivator activity | 7.99e-02 | 1.00e+00 | 2.086 | 2 | 21 | 184 |
GO:0071407 | cellular response to organic cyclic compound | 8.36e-02 | 1.00e+00 | 3.522 | 1 | 2 | 34 |
GO:0007254 | JNK cascade | 8.36e-02 | 1.00e+00 | 3.522 | 1 | 1 | 34 |
GO:0031093 | platelet alpha granule lumen | 8.60e-02 | 1.00e+00 | 3.480 | 1 | 3 | 35 |
GO:0044297 | cell body | 8.60e-02 | 1.00e+00 | 3.480 | 1 | 5 | 35 |
GO:0000902 | cell morphogenesis | 8.60e-02 | 1.00e+00 | 3.480 | 1 | 5 | 35 |
GO:0050434 | positive regulation of viral transcription | 8.60e-02 | 1.00e+00 | 3.480 | 1 | 5 | 35 |
GO:0003677 | DNA binding | 8.82e-02 | 1.00e+00 | 1.044 | 5 | 52 | 947 |
GO:0008645 | hexose transport | 8.83e-02 | 1.00e+00 | 3.440 | 1 | 8 | 36 |
GO:0051216 | cartilage development | 8.83e-02 | 1.00e+00 | 3.440 | 1 | 1 | 36 |
GO:0003743 | translation initiation factor activity | 9.06e-02 | 1.00e+00 | 3.400 | 1 | 8 | 37 |
GO:0001948 | glycoprotein binding | 9.06e-02 | 1.00e+00 | 3.400 | 1 | 1 | 37 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 9.30e-02 | 1.00e+00 | 3.362 | 1 | 4 | 38 |
GO:0030216 | keratinocyte differentiation | 9.30e-02 | 1.00e+00 | 3.362 | 1 | 1 | 38 |
GO:0048511 | rhythmic process | 9.30e-02 | 1.00e+00 | 3.362 | 1 | 5 | 38 |
GO:0042803 | protein homodimerization activity | 9.43e-02 | 1.00e+00 | 1.453 | 3 | 13 | 428 |
GO:0016032 | viral process | 9.43e-02 | 1.00e+00 | 1.453 | 3 | 30 | 428 |
GO:0019827 | stem cell maintenance | 9.53e-02 | 1.00e+00 | 3.324 | 1 | 4 | 39 |
GO:0009611 | response to wounding | 1.00e-01 | 1.00e+00 | 3.252 | 1 | 2 | 41 |
GO:0003684 | damaged DNA binding | 1.00e-01 | 1.00e+00 | 3.252 | 1 | 1 | 41 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 1 | 42 |
GO:0001047 | core promoter binding | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 4 | 42 |
GO:0004386 | helicase activity | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 3 | 42 |
GO:0017053 | transcriptional repressor complex | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 2 | 42 |
GO:0051087 | chaperone binding | 1.09e-01 | 1.00e+00 | 3.118 | 1 | 3 | 45 |
GO:0001570 | vasculogenesis | 1.09e-01 | 1.00e+00 | 3.118 | 1 | 2 | 45 |
GO:0002039 | p53 binding | 1.09e-01 | 1.00e+00 | 3.118 | 1 | 4 | 45 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.09e-01 | 1.00e+00 | 1.362 | 3 | 29 | 456 |
GO:0005518 | collagen binding | 1.14e-01 | 1.00e+00 | 3.055 | 1 | 2 | 47 |
GO:0007626 | locomotory behavior | 1.14e-01 | 1.00e+00 | 3.055 | 1 | 1 | 47 |
GO:0008203 | cholesterol metabolic process | 1.14e-01 | 1.00e+00 | 3.055 | 1 | 2 | 47 |
GO:0030097 | hemopoiesis | 1.16e-01 | 1.00e+00 | 3.025 | 1 | 3 | 48 |
GO:0015758 | glucose transport | 1.16e-01 | 1.00e+00 | 3.025 | 1 | 8 | 48 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 1.18e-01 | 1.00e+00 | 2.995 | 1 | 4 | 49 |
GO:0005643 | nuclear pore | 1.23e-01 | 1.00e+00 | 2.937 | 1 | 12 | 51 |
GO:0006338 | chromatin remodeling | 1.32e-01 | 1.00e+00 | 2.828 | 1 | 7 | 55 |
GO:0005681 | spliceosomal complex | 1.32e-01 | 1.00e+00 | 2.828 | 1 | 8 | 55 |
GO:0008584 | male gonad development | 1.36e-01 | 1.00e+00 | 2.777 | 1 | 1 | 57 |
GO:0000785 | chromatin | 1.41e-01 | 1.00e+00 | 2.727 | 1 | 6 | 59 |
GO:0009952 | anterior/posterior pattern specification | 1.43e-01 | 1.00e+00 | 2.703 | 1 | 3 | 60 |
GO:0071013 | catalytic step 2 spliceosome | 1.45e-01 | 1.00e+00 | 2.679 | 1 | 5 | 61 |
GO:0002576 | platelet degranulation | 1.47e-01 | 1.00e+00 | 2.655 | 1 | 3 | 62 |
GO:0007417 | central nervous system development | 1.50e-01 | 1.00e+00 | 2.632 | 1 | 2 | 63 |
GO:0030018 | Z disc | 1.52e-01 | 1.00e+00 | 2.610 | 1 | 3 | 64 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.54e-01 | 1.00e+00 | 2.587 | 1 | 7 | 65 |
GO:0008285 | negative regulation of cell proliferation | 1.57e-01 | 1.00e+00 | 1.496 | 2 | 11 | 277 |
GO:0005178 | integrin binding | 1.60e-01 | 1.00e+00 | 2.522 | 1 | 3 | 68 |
GO:0051082 | unfolded protein binding | 1.65e-01 | 1.00e+00 | 2.480 | 1 | 5 | 70 |
GO:0010951 | negative regulation of endopeptidase activity | 1.67e-01 | 1.00e+00 | 2.460 | 1 | 2 | 71 |
GO:0016363 | nuclear matrix | 1.71e-01 | 1.00e+00 | 2.420 | 1 | 10 | 73 |
GO:0009887 | organ morphogenesis | 1.73e-01 | 1.00e+00 | 2.400 | 1 | 1 | 74 |
GO:0016605 | PML body | 1.84e-01 | 1.00e+00 | 2.306 | 1 | 5 | 79 |
GO:0016020 | membrane | 1.89e-01 | 1.00e+00 | 0.694 | 5 | 56 | 1207 |
GO:0005635 | nuclear envelope | 1.92e-01 | 1.00e+00 | 2.235 | 1 | 6 | 83 |
GO:0003690 | double-stranded DNA binding | 1.92e-01 | 1.00e+00 | 2.235 | 1 | 6 | 83 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.94e-01 | 1.00e+00 | 2.217 | 1 | 5 | 84 |
GO:0016055 | Wnt signaling pathway | 2.01e-01 | 1.00e+00 | 2.167 | 1 | 6 | 87 |
GO:0051260 | protein homooligomerization | 2.01e-01 | 1.00e+00 | 2.167 | 1 | 2 | 87 |
GO:0007165 | signal transduction | 2.08e-01 | 1.00e+00 | 0.923 | 3 | 24 | 618 |
GO:0008201 | heparin binding | 2.09e-01 | 1.00e+00 | 2.102 | 1 | 4 | 91 |
GO:0005737 | cytoplasm | 2.10e-01 | 1.00e+00 | 0.417 | 9 | 127 | 2633 |
GO:0000209 | protein polyubiquitination | 2.11e-01 | 1.00e+00 | 2.086 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.11e-01 | 1.00e+00 | 2.086 | 1 | 6 | 92 |
GO:0046872 | metal ion binding | 2.12e-01 | 1.00e+00 | 0.742 | 4 | 24 | 934 |
GO:0006260 | DNA replication | 2.15e-01 | 1.00e+00 | 2.055 | 1 | 9 | 94 |
GO:0007219 | Notch signaling pathway | 2.17e-01 | 1.00e+00 | 2.040 | 1 | 2 | 95 |
GO:0008017 | microtubule binding | 2.21e-01 | 1.00e+00 | 2.010 | 1 | 9 | 97 |
GO:0006457 | protein folding | 2.21e-01 | 1.00e+00 | 2.010 | 1 | 5 | 97 |
GO:0006413 | translational initiation | 2.25e-01 | 1.00e+00 | 1.980 | 1 | 6 | 99 |
GO:0044267 | cellular protein metabolic process | 2.27e-01 | 1.00e+00 | 1.150 | 2 | 14 | 352 |
GO:0031012 | extracellular matrix | 2.41e-01 | 1.00e+00 | 1.868 | 1 | 4 | 107 |
GO:0000790 | nuclear chromatin | 2.45e-01 | 1.00e+00 | 1.841 | 1 | 9 | 109 |
GO:0006397 | mRNA processing | 2.47e-01 | 1.00e+00 | 1.828 | 1 | 12 | 110 |
GO:0042981 | regulation of apoptotic process | 2.51e-01 | 1.00e+00 | 1.802 | 1 | 4 | 112 |
GO:0008022 | protein C-terminus binding | 2.57e-01 | 1.00e+00 | 1.764 | 1 | 5 | 115 |
GO:0007049 | cell cycle | 2.57e-01 | 1.00e+00 | 1.764 | 1 | 8 | 115 |
GO:0005578 | proteinaceous extracellular matrix | 2.57e-01 | 1.00e+00 | 1.764 | 1 | 4 | 115 |
GO:0006355 | regulation of transcription, DNA-templated | 2.76e-01 | 1.00e+00 | 0.713 | 3 | 31 | 715 |
GO:0019904 | protein domain specific binding | 2.85e-01 | 1.00e+00 | 1.587 | 1 | 4 | 130 |
GO:0009897 | external side of plasma membrane | 2.87e-01 | 1.00e+00 | 1.576 | 1 | 3 | 131 |
GO:0006351 | transcription, DNA-templated | 2.94e-01 | 1.00e+00 | 0.538 | 4 | 47 | 1076 |
GO:0003714 | transcription corepressor activity | 2.98e-01 | 1.00e+00 | 1.512 | 1 | 5 | 137 |
GO:0030168 | platelet activation | 3.05e-01 | 1.00e+00 | 1.470 | 1 | 5 | 141 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 3.07e-01 | 1.00e+00 | 1.460 | 1 | 7 | 142 |
GO:0001701 | in utero embryonic development | 3.28e-01 | 1.00e+00 | 1.343 | 1 | 7 | 154 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 3.40e-01 | 1.00e+00 | 1.279 | 1 | 18 | 161 |
GO:0005874 | microtubule | 3.44e-01 | 1.00e+00 | 1.261 | 1 | 10 | 163 |
GO:0016071 | mRNA metabolic process | 3.56e-01 | 1.00e+00 | 1.200 | 1 | 10 | 170 |
GO:0019221 | cytokine-mediated signaling pathway | 3.59e-01 | 1.00e+00 | 1.183 | 1 | 10 | 172 |
GO:0006412 | translation | 3.69e-01 | 1.00e+00 | 1.134 | 1 | 12 | 178 |
GO:0006954 | inflammatory response | 3.80e-01 | 1.00e+00 | 1.078 | 1 | 3 | 185 |
GO:0005975 | carbohydrate metabolic process | 3.82e-01 | 1.00e+00 | 1.070 | 1 | 10 | 186 |
GO:0016567 | protein ubiquitination | 3.85e-01 | 1.00e+00 | 1.055 | 1 | 14 | 188 |
GO:0016070 | RNA metabolic process | 3.85e-01 | 1.00e+00 | 1.055 | 1 | 10 | 188 |
GO:0005856 | cytoskeleton | 3.88e-01 | 1.00e+00 | 1.040 | 1 | 8 | 190 |
GO:0005743 | mitochondrial inner membrane | 4.00e-01 | 1.00e+00 | 0.987 | 1 | 9 | 197 |
GO:0005525 | GTP binding | 4.00e-01 | 1.00e+00 | 0.987 | 1 | 12 | 197 |
GO:0043065 | positive regulation of apoptotic process | 4.07e-01 | 1.00e+00 | 0.951 | 1 | 7 | 202 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 4.09e-01 | 1.00e+00 | 0.944 | 1 | 14 | 203 |
GO:0008134 | transcription factor binding | 4.18e-01 | 1.00e+00 | 0.902 | 1 | 10 | 209 |
GO:0019899 | enzyme binding | 4.20e-01 | 1.00e+00 | 0.895 | 1 | 7 | 210 |
GO:0043234 | protein complex | 4.20e-01 | 1.00e+00 | 0.895 | 1 | 13 | 210 |
GO:0030054 | cell junction | 4.32e-01 | 1.00e+00 | 0.841 | 1 | 5 | 218 |
GO:0006200 | ATP catabolic process | 4.33e-01 | 1.00e+00 | 0.835 | 1 | 13 | 219 |
GO:0007186 | G-protein coupled receptor signaling pathway | 4.48e-01 | 1.00e+00 | 0.770 | 1 | 4 | 229 |
GO:0007155 | cell adhesion | 4.69e-01 | 1.00e+00 | 0.679 | 1 | 8 | 244 |
GO:0005829 | cytosol | 4.93e-01 | 1.00e+00 | 0.128 | 5 | 88 | 1787 |
GO:0046982 | protein heterodimerization activity | 4.98e-01 | 1.00e+00 | 0.560 | 1 | 11 | 265 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.98e-01 | 1.00e+00 | 0.279 | 2 | 29 | 644 |
GO:0009986 | cell surface | 5.31e-01 | 1.00e+00 | 0.425 | 1 | 5 | 291 |
GO:0000278 | mitotic cell cycle | 5.59e-01 | 1.00e+00 | 0.315 | 1 | 28 | 314 |
GO:0055085 | transmembrane transport | 5.76e-01 | 1.00e+00 | 0.248 | 1 | 13 | 329 |
GO:0007596 | blood coagulation | 5.87e-01 | 1.00e+00 | 0.204 | 1 | 13 | 339 |
GO:0070062 | extracellular vesicular exosome | 6.26e-01 | 1.00e+00 | -0.071 | 4 | 51 | 1641 |
GO:0005783 | endoplasmic reticulum | 6.31e-01 | 1.00e+00 | 0.036 | 1 | 12 | 381 |
GO:0006915 | apoptotic process | 6.59e-01 | 1.00e+00 | -0.073 | 1 | 15 | 411 |
GO:0005887 | integral component of plasma membrane | 7.81e-01 | 1.00e+00 | -0.558 | 1 | 8 | 575 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 7.85e-01 | 1.00e+00 | -0.575 | 1 | 22 | 582 |
GO:0005615 | extracellular space | 8.22e-01 | 1.00e+00 | -0.737 | 1 | 15 | 651 |
GO:0005576 | extracellular region | 8.28e-01 | 1.00e+00 | -0.763 | 1 | 15 | 663 |
GO:0008270 | zinc ion binding | 8.56e-01 | 1.00e+00 | -0.896 | 1 | 39 | 727 |
GO:0005886 | plasma membrane | 8.61e-01 | 1.00e+00 | -0.606 | 3 | 46 | 1784 |
GO:0044281 | small molecule metabolic process | 8.96e-01 | 1.00e+00 | -1.112 | 1 | 35 | 844 |
GO:0016021 | integral component of membrane | 9.86e-01 | 1.00e+00 | -1.966 | 1 | 19 | 1526 |